Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline as add-on therapy in COVID-19
NCT04433988Phase 2Withdrawn
- Sponsor
- Sadat City University
- Start
- Nov 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline in coronavirus disease 2019 (COVID-19), sponsored by Sadat City University. Planned start Nov 2022; status: withdrawn.
02
Drugs
pentoxifylline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04433988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433988.